ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
ResMed (RMD) Reports In-Line Q4 EPS, Revenues Slightly Beat
August 2, 2018 4:36 PM EDTResMed (NYSE: RMD) reported Q4 EPS of $0.95, in-line with the analyst estimate of $0.95. Revenue for the quarter came in at $623.6 million versus the consensus estimate of $623.2 million.
Revenue increased 12% to $623.6 million; up 10% on a constant currency basisNet income increased by 8%; non-GAAP net income up... More


